Multiple posts filled with good news from legit patients are always welcome. My only concern with the longhaulers is not efficacy. Its finding that primary endpoint for phase 3. Since symptoms are so scattered and all over the board, finding an endpoint we can hit with a good number of patients may be a challenge. Hope I'm wrong and something pops up that they can find consistently with most longhaulers.

Again, thanks for sharing!